CoChat

An integrated analysis of germline and somatic, genetic and epigenetic alterations at 9p21.3 in glioblastoma

Feng, Junjie, Kim, Seong‐Tae, Liu, Wennuan, Kim, Jin Woo, Zhang, Zheng, Zhu, Yi, Berens, Michael, Sun, Jielin, Xu, Jianfeng · 2012 · Cancer
Cited by 38

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Glioblastoma multiforme (GBM) is the most prevalent and deadly brain tumor. A variety of germline and somatic, genetic and epigenetic alterations at 9p21.3, which encode CDKN2A / CDKN2B tumor suppressor genes, have been isolatedly reported to be associated with GBM risk and prognosis. METHODS: To obtain a comprehensive view of these events, we leveraged the wide‐spectrum GBM data available from The Cancer Genome Atlas project and performed an integrated analysis by systematically evaluating 9p21.3‐related germline single‐nucleotide polymorphisms, somatic copy number alterations (CNAs), DNA methylation, and microRNAs (miRNAs) with regard to CDKN2A / CDKN2B expression and patient prognosis in GBM. RESULTS: Our multivariate analysis indicated that expression of CDKN2A and CDKN2B was both strongly affected by CNAs ( P = 1.00 × 10 −4 and 2.37 × 10 −14 ). The miRNAs hsa‐mir‐126, hsa‐mir‐517a, and hsa‐mir‐125b exhibited significant negative correlations with CDKN2A expression ( P = 0.003, 0.041, and 0.050). Survival analysis showed that complete 9p21.3 loss and low CDKN2B expression were associated with worse prognosis for both tumor progression/recurrence‐free survival ( P = .041 and .019) and patient overall survival ( P = .043 and .021) after adjustment for age and treatment, and that higher methylation at cg17449661 predicted poorer overall survival ( P = .048). CONCLUSION: Representing one of the first attempts to systematically integrate various levels of alterations associated with the often complex cancer genomes and phenotypes, our study provided a holistic view and a mechanistic explanation over the functional connections of multiple 9p21.3‐related events in GBM, as well as clinically useful biomarker information for predicting disease outcomes. Cancer 2012;. © 2011 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.26250

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 38

Metadata

Authors
Feng, J., Kim, S., Liu, W., Kim, J. W., Zhang, Z., Zhu, Y., Berens, M., Sun, J., & Xu, J.
Venue
Cancer
Publisher
Wiley
Published
2011-06-28
Volume
118
Issue
1
Pages
232-240
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W1553966318
Cited by
38
References
4
FWCI
2.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An integrated analysis of germline and somatic, genetic and epigenetic alterations at 9p21.3 in glioblastoma. https://app.cochat.ai/papers/10.1002/cncr.26250
The paper
Feng, J., Kim, S., Liu, W., Kim, J. W., Zhang, Z., Zhu, Y., Berens, M., Sun, J., & Xu, J. (2012). An integrated analysis of germline and somatic, genetic and epigenetic alterations at 9p21.3 in glioblastoma. Cancer. https://doi.org/10.1002/cncr.26250

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.